European Patent Office

T 0694/16 of 15.05.2019

European Case Law Identifier
ECLI:EP:BA:2019:T069416.20190515
Date of decision
15 May 2019
Case number
T 0694/16
Petition for review of
-
Application number
08766831.5
Language of proceedings
English
Distribution
Distributed to board chairmen (C)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
FOOD COMPOSITION FOR PRODROMAL DEMENTIA PATIENTS
Applicant name
N.V. Nutricia
Opponent name
Fresenius Kabi Deutschland GmbH
Nestec S.A.
Board
3.3.09
Headnote
-
Keywords
Main request: sufficiency of disclosure (no)
Auxiliary request 4: added matter (no), sufficiency of disclosure (yes), novelty (yes), priority right (yes)
Catchword
If a claim is directed to a known compound or composition for use in a therapeutic method of treatment or prevention of a disease, and the claim specifies that the subject to be treated displays a clearly defined and detectable marker, which is not displayed by all subjects affected by or likely to develop that disease, then the purposive selection of the patients displaying the marker for the specified treatment is a functional feature characterising the claim. (Points 5.1-5.21 of the Reasons)

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division for further prosecution upon the basis of auxiliary request 4 filed under cover of a letter dated 6 June 2016.